Beruflich Dokumente
Kultur Dokumente
Oxygen-Generating
Biomaterials: A New, Viable
Paradigm for Tissue
Engineering?
Mazaher Gholipourmalekabadi,1,2 Susan Zhao,3
Benjamin S. Harrison,3 Masoud Mozafari,4,* and
Alexander M. Seifalian5,6,*
There have been many attempts to provide sufcient nutrients, especially
Trends
oxygen, to engineered large tissues to overcome the effects of hypoxia or poor
The successful outcome of organs
vascularization. Delivering sufcient oxygen to the transplanted cells is one made from tissue engineering princi-
of the most critical issues that affects cell survival and correct maturation of pally depends on delivery of sufcient
nutrients, especially oxygen to cells for
engineered tissues. An emerging approach is using 3D scaffolds made from the initial period of the formation of
oxygen-generating biomaterials to tackle transport limitations deep within the microvasculature in the construct.
engineered tissues. This class of biomaterials has opened a new window for
An emerging approach is using 3D
overcoming the challenges associated with ischemia occurring within large scaffolds made from oxygen-generat-
tissue constructs. This review critically assesses oxygen-generating reagents, ing biomaterials to tackle transport lim-
itations deep within the engineered
the main approaches for developing oxygen-generating biomaterials, and their
tissues.
potential as 3D scaffolds for regenerative medicine in a clinical setting.
This class of biomaterials has opened a
new window for overcoming the chal-
Oxygen Requirements in Engineered Tissues lenges associated with ischemia occur-
We are facing an ageing population with an increasing a number of damaged and failing organs. ring within large tissue constructs.
The greatest challenges facing the eld of organ transplantation today are a shortage of organs,
This review critically assesses oxygen-
the lack of available organ donors, high cost of transplantation, and morbidity and mortality of generating reagents, the main
consequent life-long immunosuppression [1]. Tissue engineering (TE) has opened a new approaches for developing oxygen-
window of opportunity for supplying organ substitutes [24] (Box 1). An example of this was generating biomaterials, and their
potential as 3D scaffolds for regenera-
the world's rst synthetic trachea [5], which used nanocomposite 3D scaffold and a patient's tive medicine in a clinical setting.
own stem cells (Figure 1).
Despite remarkable progress in the TE eld, some continued challenges remained unsolved [6].
One of the major problems associated with tissue transplantation is sufciently supplying oxygen
and nutrients to meet the demands of cells in 3D cellular engineered constructs following
1
transplantation. This drawback could critically limit the development of functional tissue for Cellular and Molecular Research
Center, Iran University of Medical
human TE. It has been reported that a TE 3D scaffold requires interconnected pores with a pore Sciences, Tehran, Iran
diameter of at least 100 mm to allow for sufcient nutrient transport [7]. Oxygen deciency occurs 2
Department of Tissue Engineering
when the distance between cell and blood vessels exceed 100200 mm [8]. and Regenerative Medicine, Faculty of
Advanced Technologies in Medicine,
Iran University of Medical Sciences,
Adequate and homogeneous nutrient distribution, especially oxygen, facilitates cell migration, Tehran, Iran
3
neovascularization (see Glossary) and tissue ingrowth [9]. The level of hypoxia in the central Wake Forest Institute for
Regenerative Medicine, Wake Forest
part of the scaffold is higher than that in the periphery. Therefore, cells that migrate into the School of Medicine, Winston-Salem,
depths of the scaffold are often exposed to hypoxic conditions [10]. While adequate oxygen NC, USA
*Correspondence:
mozafari.masoud@gmail.com
Epidermal Adipose-derived Adipose-derived MSCs / MSCs /
(M. Mozafari) and a.seifalian@gmail.com
stem cells stem cells stem cells Perichondrocytes Osteoblasts
(A.M. Seifalian).
Mineralized
Matrix Growth Mechano-electrical Chondrogenic substrates /
proteins factors Vasculogenesis smulaon / factors osteogenic
promong factors myogenic factors factors
Figure I. Tissue Engineering Strategies for Organ Development. (First row) Source and isolation of stem cells/
cells, usually autologous. Abbreviation: MSCs, mesenchymal stem cells. (Second row) 3D scaffolds, where oxygen-
generating biomaterials may enhance the formation of the microvasculature. (Third row) Growth factors, peptides, or
stimulation to enhance cell proliferation and integration to the surrounding tissue. (Fourth row) Constructs can be placed
in bioreactors in vitro or inside patients in vivo prior to transplantation [6].
diffusion facilitates graft maturation, its absence ultimately often results in poor extracellular
matrix deposition and/or cell death and tissue necrosis [11].
The cell behavior in hypoxic conditions and recent efforts employed to resupply oxygen
deciency in hypoxic conditions are described in Box 2.
Oxygen diffusion becomes more critical when cells or cell/scaffold constructs are implanted in
defects larger than a few millimeters [12].
Cells die in hypoxic conditions due to their inability to aerobically respire. Respiration allows for the
production of adenosine triphosphate (ATP). ATP molecules are necessary for survival because of
the numerous chemical reactions in cells in which they are involved. Tissue damage is a major
cause of tissue hypoxia because it destroys the network of vascularization, which prevents
Delivery of insulin-producing cells to the pancreas is one strategy for the treatment of diabetes. However, there are some
challenges associated with delivery of such cells, including an unfavorable immune response and inability in providing
sufcient oxygen supply. b Cells have a high oxygen demand for normal activity and functionality.
oxygen from reaching large areas of tissue, hence depriving the cells of oxygen. Environments of
low oxygen promote the production of free radicals, which have the potential to damage
deoxyribonucleic acid (DNA), cause mutations, and arrest the cell cycle. By contrast, some cells
such as b cells (in the pancreas), muscle cells, hepatocytes, and neurons are cells with high
oxygen demands. Therefore, such cells are very sensitive to hypoxic conditions. To prevent
further damage, it is imperative to provide damaged tissue with a sufcient oxygen supply.
Although recent strategies had partial successes in supplying oxygen, failure to supply sufcient
oxygen in a consistent manner over time to support the tissue until host neovascularization is
achieved has remained challenging for large tissue masses. Despite several attempts in this
regard, there is no efcient strategy for compensating low oxygen pressure in the vascular
destroyed areas. Recent efforts have focused on designing oxygen-releasing biomaterials
(ORBs) to provide a sustained and localized delivery of oxygen to engineered tissues [14]. In
this article, we critically review the development of ORBs and the mechanisms by which these
materials deliver oxygen. In addition, the applications of this emerging eld of study are
discussed in TE and in clinical settings. We also aim to introduce the salient features of this
class of biomaterials, the hurdles that must be overcome, the hopes associated with it, and
practical constraints to develop this strategy for different tissues.
Oxygen-Releasing Biomaterials
ORBs have a potential application in providing sufcient and prolonged oxygen supply for
engineered tissue both in vitro and in vivo in the clinical setting [15,16]. These materials release
oxygen by diffusion of entrapped, adsorbed oxygen or by chemical generation of oxygen.
Oxygen-generating biomaterials (OGBs) comprise a subclass of ORBs. These classes of
materials are designed to provide a gradual release of oxygen to cells as rapid or high
concentration of oxygen potentially causes cell death due to the formation of free radicals
[17]. The controlled gradual release is the key parameter for viable outcome of organs, especially
benecial to provide adequate time for early neovascularization and maturation of the engineered
tissue [18]. To prolong the release of oxygen, these materials have been incorporated into tissue
engineered constructs in various forms such as microspheres [17], lms [13], electrospun
nanobers [19], and scaffolds [11]. Sodium percarbonate (SPO) [13], calcium peroxide
(CaO2) [11,18], magnesium peroxide (MgO2) [13], hydrogen peroxide (H2O2) [20], and uori-
nated materials [21] are of the most common ORBs. It has also been suggested that encap-
sulation of such biomaterials in a hydrophobic polymer could remarkably slow down the release
of oxygen. Additionally, chemical components of the OGBs could affect the consistency of
oxygenation [13]. For example, OGBs produce oxygen when exposed to water. The rate and
speed of the oxygenation depends on factors such as pH, temperature, purity, and solubility of
peroxides, as well as presence of specic buffers or catalysts [16]. OGBs produce metal
hydroxides upon oxygen decomposition after exposure to water, which increases the pH of
the microenvironment and ultimately affects the rate of oxygen generation. Therefore, buffers are
commonly used to adjust the pH.
Some OGBs (such as calcium peroxide) produce reactive oxygen species as a byproduct during
oxygen decomposition. Accumulation of hydrogen peroxide (H2O2) as a residual reactive oxygen
species could remarkably increase the production of free radicals and reduce cell viability.
Therefore, catalase, an enzyme found in almost all living cells that is responsible for decom-
posing hydrogen peroxide to water and oxygen, can be introduced as an antioxidant to
accelerate decomposition of H2O2. After OGBwater interaction, the released H2O2 is decom-
posed into oxygen, as a useful and safe product for combatting hypoxia, by catalase present
within the engineered scaffold. For in vivo application of OGBs, catalase, as an antioxidant, can
also be incorporated into the engineered scaffolds to minimize the cytotoxicity effects of the
accumulated hydrogen peroxide (H2O2), an alternative product of OGBwater interaction [11].
Figure 2. (A) H2O2-PLGA-catalase/Alginate [20]. (B) H2O2 was xed to PVP, encapsulated in PLGA, and surrounded with
catalase-containing hydrogel [17]. Abbreviations: H2O2, hydrogen peroxide; PLGA, poly(D,L-lactide-co-glycolide); PVP, poly
(vinyl pyrrolidone).
peroxide was released from the PLGA (Figure 2A), a small amount of H2O2 degrades and
produces oxygen, while the majority of H2O2 is released into the secondary layer. The catalase
present in the alginate layer decomposes the remaining H2O2 into oxygen. It was also indicated
that decreasing the thickness of the alginate layer remarkably increased the rate of oxygen
diffusion across the construct. It has been noted that this nding was due to increased porosity
of the alginate when the concentration was decreased to 10% [20]. H2O2 has also been used in
an injectable form to design an oxygen supplier for augmentation of cell survival and cardio-
sphere-derived cell (CDC) differentiation in a simulated hypoxic condition (1% O2). First, H2O2
was bound to poly(vinyl pyrrolidone) (PVP). The PVP/H2O2 complex was encapsulated in PLGA
to form a core shell microsphere. The resultant microsphere was placed in an injectable and
thermo-sensitive, catalase-containing hydrogel (Figure 2B). The hydrogel was used to retain
stem cells and suspend the PVP/H2O2/PLGA microspheres in an injectable form. This construct
could mimic hypoxic conditions that arise during myocardial infarction. It has been reported that
hydrogels can protect polymers and prolong the release of oxygen up to 1 week [20]. Ultimately,
the duration of oxygen release time must be increased to a couple of weeks to allow for
neovascularization. As reported previously, the rate of release decreases as the molecular
weight of the polymer increases [17]. It has been noted that PVP can bind to H2O2 and form a
stable complex, leading to a more gradual release of oxygen. It was demonstrated that PVP/
H2O2/PLGA/catalase/hydrogel increased the durability of oxygen release for at least 14 days.
In our previously published study [13], SPO was incorporated into PLGA lms using a solvent
casting technique to engineer a material with sustained release of oxygen. A high rate of oxygen
release was observed during the rst day while total oxygen generation was completed over the
rst 70 h. The prolonged and consistent production of oxygen is of the utmost importance in the
elimination of hypoxic conditions following tissue injuries. This group carried out another study by
Oh et al. [11] to develop a method for slowing down the release of oxygen. For this purpose, they
encapsulated calcium peroxide (CPO) in PLGA and evaluated in vitro oxygen generation over the
rst 10 days. To assay the amount and consistency of oxygen release, the engineered construct
(PLGA/CPO) was embedded into a media under hypoxia conditions (0.5% O2, 5% CO2, 378C). It
was reported that small oxygen bubbles were observed upon embedding the engineered
construct in media. Furthermore, oxygen generation was prolonged over 10 days without much
change in pH, which remained between 7.2 and 7.6. In cell cultures, PLGA containing 5% CPO
had signicantly higher cell count up to 72 h among the 0%, 1%, and 10% CPOPLGA
constructs.
The commonly used peroxides are in the form of solids; however, recently a liquid H2O2
oxygen-releasing system has been proposed, to see whether it is capable of sustainably
supplying oxygen to stem cells [17]. Their proposed oxygen-release system consisted of H2O2-
releasing PLGA microspheres, catalase, and an injectable thermo-sensitive hydrogel based
from N-isopropylacrylamide (NIPAAm), acrylic acid (AAc), and a macromer hydroxyethyl
methacrylateoligo(hydroxybutyrate) (HEMAoHB).
While most of the examples of OGBs involve inorganic peroxides, recently there have been
reports of organic-based oxygen-generating materials. Methylated pyridone-derived endoper-
oxides that are water-soluble can undergo reactions in an aqueous environment to release
oxygen in high yield and with half-lives of up to 13 h. These molecules, in combination with
vitamin C as singlet oxygen quencher, signicantly improved survival of 3T3 broblasts and rat
smooth muscle cells challenged with oxygen-depleted conditions. Singlet oxygen (1O2) is a high-
energy state of oxygen that can react readily with electron-rich double bonds and cause cellular
damage through oxidizing the cellular components.
In a study, a stable PFC-encapsulated alginate was synthesized, with consistent oxygen release
of more than 7 days in vitro [23]. The prepared construct was expected to be capable of
encapsulating islets for the growth and production of insulin, as well as encapsulation of stem
cells for proliferation and differentiation into cells of interest. Therefore, the investigation of such
constructs in vivo is worthy of future testing.
Another approach is functionalized hyaluronic acid derivatives with uorinated oxadiazole (OXA)
moieties, as a PFC, to develop a new oxygenating system [24]. The prepared system reacted
with a vinyl sulfone derivative of inulin to form an injectable hydrogel. The presence of PFC
positively affected the mechanical properties of the resultant hydrogel and signicantly promoted
metabolic activity and viability of broblasts up to 7 days. The system increased the solubility of
related gases [24] and mitigated the effects of hypoxia compared with analogous unuorinated
systems. A summary of recently conducted studies in vivo, as well as their ndings and
limitations, is listed in Table 1.
CPO Four different constructs The rate and initial burst of Low oxygenation (W. Schlgl,
including CPOhard fat, O2 decreased with consistency. PhD thesis,
CPOPLGA, CPOEC, increased particle size. Ludwig
and CPOECcatalase CPOhard fat and CPO Needs to be tested for Maximilan
collagenceramic PLGA showed high rates oxygenation consistency University
composite. of O2 initial burst. over longer periods of Munich,
CPOEC was able to time. 2012)
CPO was granulated in decrease the initial burst
hard fat, PLGA, and EC. of oxygenation, so that O2 Requires further in vivo
CPOEC granules were was produced up to 72 h. investigations.
incorporated in catalase-
containing collagen The presence of catalase
ceramic composite. in CPOcollagenceramic
composite decreased
cytotoxicity of the
released hydrogen
peroxide and increased
effectiveness of the
strategy.
Abbreviations: A, alginate; CPO, calcium peroxide; EC, ethyl cellulose; H2O2, hydrogen peroxide; MACF, uorinated
a
methacrylamide chitosan; O2, oxygen; OGBs, oxygen-generating biomaterials; PFC, peruorocarbon; PCL, polycapro-
lactone; PDMS, polydimethylsiloxane; PLGA, poly(D,L-lactide-co-glycolide); PVP, poly(vinyl pyrrolidone).
Oxygen-Generating Mechanisms
In considering materials for TE applications, biocompatibility is key [25,26]. However, the rate of
oxygen release from these materials is actually the most important factor that directly inuences
the formation of new tissues. The oxygen release mechanism needs to be adjustable for
sustained release based on the needs of the target tissue. If there is a signicant burst effect
or very prolonged release behavior, the system cannot deliver a consistent, satisfactory amount
of oxygen for living cells to maintain healthy cellular function. To correctly adjust the oxygen
formation rate from peroxide compounds, a number of factors, such as temperature, pH,
amount of peroxide, and type of medium, must be considered [27].
2H2 O2 ! O2 2H2 O
All of these peroxides have been reported to be useful in TE [2931], but due to the availability of
higher purity commercial formulations (around 70% purity), CaO2 has been shown to be the
most promising oxygen generation [14,32]. In contrast, MgO2 has been shown to be the slowest
oxygen formation due to its lower solubility and consequently slower reaction rate. In the case of
adding peroxide compounds as llers in polymeric composites, the characteristics of the matrix
could also affect the oxygen release behavior. It has been shown that entrapment in more
hydrophobic materials may slow down the rate of oxygen release, while encapsulation in
more hydrophilic materials may increase the diffusion rate due to the rapid diffusion of water
into the structure [30].
Pancreas
Diabetes is a growing problem caused by the inability of the pancreas to regulate blood glucose
levels. The essential of oxygen requirements for pancreas tissue regeneration is summarized in
Box 2. Several studies have been conducted to provide a sufcient level of oxygen for islet cells
[18,33] with different ranges of success. Recently, researchers have adopted OGBs to explore a
way for overcoming the delivery of oxygen. Pedraza et al. [18] developed a novel construct made
of polydimethylsiloxane (PDMS)-encapsulated solid calcium peroxide (PDMSCaO2) to enhance
the durability of oxygen release. PDMS is a highly hydrophobic and biostable polymer. As
expected, the reduction in water uptake remarkably decreased the rate of decomposition of the
encapsulated OGBs and resulted in the enhanced consistency of oxygen release. PDMSCaO2
was fabricated in disc form and then embedded in b cell-laden agarose gels. The encapsulation
Table 2. A List of Studies That Evaluated Oxygen-Generating Biomaterials In Vivo as well as Their Findings
and Limitationsa
Tissue Final Construct Findings and Limitations Refs
Dermis SPOPLGA: various concentrations of SPO The prepared lm delayed the onset of necrosis [13]
were incorporated into PLGA to prepare an by up to 3 days when implanted in the skin ap
SPO-containing PLGA lm. model.
Necrosis occurred after 7 days in an SPOPLGA
implanted animal, similar to a control.
Muscle SPO was injected in a rat model with partial Increased contractility of muscle cells in vivo was [16]
hindlimb hypoxia. observed.
Decreased oxidative stress, HIF1/
accumulation, and metabolic activity over 24 h
were observed.
a
Abbreviations: PLGA, poly(D,L-lactide-co-glycolide); SPO, sodium percarbonate; HIF1/, hypoxia-inducible factor 1/.
Skin Regeneration
Similar to other tissues, one of the major challenges in dermal wound TE is insufcient oxygen
level in the transplanted site due to loss of the vascular network during injury. Ischemia in the
defected site affects the wound healing response and causes scar formation. In a study, various
PFC chains were incorporated into the methacrylamide chitosan (MACF) to develop a novel
injectable hydrogel with the capability of repeatable uptake and release of oxygen for wound
healing applications [34]. The synthesized hydrogel demonstrated a maximum uptake and
completed release of O2 at 26 and 12120 h, respectively. The uorinated MACF hydrogel was
found to be easily reloaded with oxygen upon complete oxygen depletion. It has also been
shown that the positive effects of the synthesized hydrogels on viability and metabolic activity of
the broblasts increased with a corresponding increase of PFC concentration within the
construct. The ndings obtained from their study suggest the feasibility of implementing the
MACF hydrogel in wound TE. However, future use of the MACF requires further experiments to
prove the efcacy of such hydrogels in wound healing in vivo.
The roles of oxygen in tissue regeneration, especially in wound healing, are still not clearly
understood due to the differences in results obtained in vitro and in vivo [31,35,36]. A skin ap
model has been developed as the gold standard method to mimic ischemia conditions in vivo for
investigation of tissue survival after implantation (A.D. Murphy, PhD thesis, National University of
Ireland Galway, 2015) [37]. For example, Harrison et al. [13] implanted SPO/PLGA lms as a
polymeric oxygen-generating (POG) device in a skin ap model created in nude mice. Mice
treated with SPO-doped PLGA lms showed signicantly reduced necrotic areas compared
with those of mice implanted with PLGA-only lms after 23 days. However, at day 7 post-
surgery, necrosis in animals implanted with POG-containing PLGA was observed to be similar to
controls. Lactate level, a reliable measurement that increases in hypoxic and ischemic con-
ditions, decreased in SPO/PLGA-implanted animals compared with controls. Their strategy
successfully delayed the onset of necrosis during the rst 7 days. This therapy needs a few
modications to delay oxygen release over longer periods of time. A possible way to overcome
this obstacle may be to incorporate such materials into more hydrophobic polymers [11]. By
contrast, encapsulating OGBs in such hydrophobic materials may reduce cell integration and
cell adhesion. Attempts are currently underway to determine efcient strategies to extend
oxygen generation without negatively affecting cell adhesion and cell migration.
Muscle
Muscle cells are cells with high oxygen demand. Oxygen deciency after muscle tissue replace-
ment due to poor vascular networks, especially in early stage of transplantation, leads to
ischemia and necrosis [38]. Therefore, supplying sufcient oxygen during the rst 3 weeks is
crucial to prevent hypoxia within the damaged tissues. Utilization of oxygen-producing bio-
materials as an alternative strategy has been studied for providing adequate oxygen supply with
different grades of success [16,39]. One of the successful approaches synthesized a hydrogen
peroxide-encapsulated PLGA microsphere surrounded by a secondary layer of alginate [38]. For
this purpose, different concentrations of hydrogen peroxide, ranging from 0.5% to 30.0%, were
The main concern associated with using OGBs is the production of toxic agents such as
hydrogen peroxide, residual reactive oxygen species, and salts as decomposition byproducts
(see Outstanding Questions). Moreover, factors such as the rate of hydration, the pH of the
environment, and catalysts present in the in vivo environment can remarkably affect the quality
and quantity of oxygenation. Therefore, the negative effects of such agents should be minimized.
Current efforts are being undertaken to investigate various factors that affect the release of
oxygen as well as to develop novel strategies for fabricating an ideal oxygen delivery system.
Research is focused towards developing human organs using 3D scaffolds and autologous
stem cells. These scaffolds can either be made from biological or synthetic materials, but due to
rapid progress in smart synthetic materials, especially nanotechnology-based materials, we
believe that hollow organs will move towards clinical study over the next 5 years. OGBs will play a
considerable role in this development.
References
1. Saidi, R. and Kenari, S.H. (2014) Challenges of organ shortage for 6. Yildirimer, L. and Seifalian, A. (2015) Tissue engineering. In Plastic
transplantation: solutions and opportunities. Int. J. Organ Trans- and Reconstructive Surgery: Approaches and Techniques (Far-
plant. Med. 5, 87 hadieh, R.D. et al., eds), pp. 6268, John Wiley & Sons
2. Gholipourmalekabadi, M. et al. (2015) Optimization of nanobrous 7. Dehghani, F. and Annabi, N. (2011) Engineering porous scaffolds
silk broin scaffold as a delivery system for bone marrow adherent using gas-based techniques. Curr. Opin. Biotechnol. 22,
cells: in vitro and in vivo studies. Biotechnol. Appl. Biochem. 62, 661666
785794 8. Lim, J.O. et al. (2015) Functionalized biomaterials-oxygen releas-
3. Yildirimer, L. et al. (2012) Skin regeneration scaffolds: a multimodal ing scaffolds. J. Biotechnol. Biomater. 5, 1
bottom-up approach. Trends Biotechnol. 30, 638648 9. Sarker, M. et al. (2015) Experimental approaches to vascularisa-
4. Reddy, N. et al. (2015) Crosslinking biopolymers for biomedical tion within tissue engineering constructs. J. Biomater. Sci. Polym.
applications. Trends Biotechnol. 33, 362369 Ed. 26, 683734
5. Jungebluth, P. et al. (2011) Tracheobronchial transplantation with 10. Becquart, P. et al. (2012) Ischemia is a prime but not the only
a stem-cell-seeded bioarticial nanocomposite: a proof-of-con- cause of hMSC death in tissue engineered constructs in vivo. Tiss.
cept study. Lancet 10, 19972004 Eng. A 18, 20842094